说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 前列腺特异6次跨膜上皮抗原
1)  Prostatic-specific six-transmembrane epithelial antigen
前列腺特异6次跨膜上皮抗原
2)  six-transmembrane epithelial antigen of the prostate
前列腺跨膜上皮抗原
1.
Objective: To investigate the relationship between six-transmembrane epithelial antigen of the prostate (STEAP) expression and the histologic grading of prostatic carcinoma (PCa).
目的 :探讨前列腺跨膜上皮抗原 (STEAP)在前列腺癌 (PCa)组织中的表达及与肿瘤病理分级之间的关系。
3)  Prostate specific membrane antigen
前列腺特异性膜抗原
1.
Prostate specific membrane antigen expression of prostatic adenocarcinoma and the relationship between PSMA expression and histologic grade;
前列腺特异性膜抗原表达的临床意义
2.
Objective:To investigate the effects of treatment of prostate cancer by high intensity focused ultrasound(HIFU) on serum prostate specific membrane antigen(PSMA) and activation of cytotoxic T lymphocytes.
目的:研究超声聚能刀(HIFU)治疗前列腺癌对血清前列腺特异性膜抗原(PSMA)水平变化及特异性激活细胞毒性T淋巴细胞活性的影响。
3.
Objective: To screen and characterize the variable region gene about prostate specific membrane antigen(PSMA) of the Chinese Fab fragment,and to establish a new approach to researches on PSMA and prostate gene therapy.
目的:筛选、鉴定抗中国人前列腺特异性膜抗原(PSMA)的人源Fab抗体可变区的编码基因,为PSMA蛋白质生物学功能的研究及前列腺癌的基因治疗研究开辟新途径。
4)  prostate-specific membrane antigen
前列腺特异性膜抗原
1.
Construction of bicistronic DNA vaccine expressing prostate-specific membrane antigen and granulocyte-macrophage colony-stimulating factor and determination of its activity;
前列腺特异性膜抗原、粒细胞-巨噬细胞集落刺激因子双顺反子DNA疫苗的构建及其免疫活性的测定
2.
Molecular cloning of a complementary DNA encoding prostate-specific membrane antigen and its usage in detection of patients with prostatic carcinoma;
前列腺特异性膜抗原cDNA的克隆及用于临床前列腺癌的检测
3.
Objective To construct the tumor cells model expressing prostate-specific membrane antigen(PSMA) for the research of anti-tumor effect and immune mechanism about the DNA vaccine.
目的构建表达前列腺特异性膜抗原(PSMA)的肿瘤细胞模型,为基因疫苗的抑瘤效应研究及免疫机制的探讨提供实验材料。
5)  prostate-specific membrane antigen(PSMA)
前列腺特异性膜抗原
1.
Prostate cancer cells are known to secrete significant amounts of prostate-specific antigen(PSA),human glandular kallikrein 2(hK2) and prostate-specific membrane antigen(PSMA),which represents a target for selectively releasing an anticancer agent from a prodrug formulation.
前列腺癌细胞特异性地分泌大量的前列腺特异性抗原(PSA)、人腺激肽释放酶2(hK2)和前列腺特异性膜抗原(PSMA),设计合成被PSA,hK2和PSMA水解活化的前药,可以针对前列腺癌进行靶向治疗。
6)  Prostate-specific membrane antigen
前列腺特异膜抗原
1.
Advance in research on prostate-specific membrane antigen
前列腺特异膜抗原的研究进展
2.
Objective To construct secretary recombinant adenoviral vector carrying the mouse prostate-specific membrane antigen gene through AdEasy vector system and the immunological outcome was assessed.
目的构建分泌型重组小鼠前列腺特异膜抗原腺病毒(Ad-mPSMA),并检测其免疫效果。
补充资料:鳞状上皮细胞癌抗原


鳞状上皮细胞癌抗原


1977年首次从子宫颈鳞状上皮细胞癌中分离出来的一种分子量为48000的糖蛋白,有很高的特异性,是外阴、阴道、子宫颈鳞状上皮细胞癌最有效和敏感的标志物。在化疗开始治疗2~3个月时,便可由血清SCE水平上升或下降得到病情变化的信息。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条